Study of ST266 Versus Saline in Treating Skin Irritation From Radiation

Radiation-induced Dermatitis Clinical Trial

Official title:
Phase I Randomized, Blinded Safety and Efficacy Trial of Amnion-derived Cellular Cytokine Solution (ACCS) Versus Saline Sprayed on the Breast of Women Undergoing Radiation Therapy for Breast Cancer After Surgical Removal of the Tumor

Status Completed

Clinical Trial Summary

The objective of this study is to evaluate the safety and efficacy of ST266 in treating radiation burns of the skin in patients undergoing treatments for breast cancer and to compare ST266 treated burns with those treated with saline placebo controls.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01714973
Study type	Interventional
Source	Noveome Biotherapeutics, formerly Stemnion
Contact
Status	Completed
Phase	Phase 1
Start date	October 2012
Completion date	October 2015

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02556632` - Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer	Phase 2
Completed	`NCT02369835` - Modified Dakin's Solution in Reducing Radiation-Induced Dermatitis in Patients With Head and Neck Cancer Undergoing Radiation Therapy	Phase 3
Recruiting	`NCT05284487` - Clinical Trial to Evaluate Safety and Efficacy of Jalosome® Soothing Gel.	N/A
Completed	`NCT03374995` - Topical Keratin in Treating Radiation Dermatitis in Patients With Breast Cancer	N/A
Not yet recruiting	`NCT05114226` - A Study for Assessing the Efficacy and Safety of Tetrahydrobiopterin in Radiation-Induced Skin Injury	Phase 1
Withdrawn	`NCT05073172` - StrataXRT for the Prevention and Treatment of Radiation Dermatitis in Breast Cancer or Head and Neck Cancer Patients	N/A
Completed	`NCT01246973` - Oral Curcumin for Radiation Dermatitis	Phase 2/Phase 3